**Core Concept**
The question is testing the association between a genetic defect and a specific type of endometrial cancer, specifically endometrioid type. Endometrioid endometrial carcinoma is a common subtype of endometrial cancer, and genetic alterations play a crucial role in its development.

**Why the Correct Answer is Right**
Endometrioid endometrial carcinoma is often associated with mutations in the PTEN gene. PTEN is a tumor suppressor gene that regulates cell growth and division by inhibiting the PI3K/AKT signaling pathway. Loss of PTEN function leads to uncontrolled cell growth and tumorigenesis. The PTEN gene is a key player in the development of endometrioid endometrial carcinoma, particularly in the presence of estrogen exposure, which is common in women with obesity and type 2 diabetes.

**Why Each Wrong Option is Incorrect**
* **Option A:** Mutations in the TP53 gene are more commonly associated with high-grade serous ovarian cancer and other types of cancer, but not specifically with endometrioid endometrial carcinoma.
* **Option B:** Mutations in the BRCA1 and BRCA2 genes are associated with breast and ovarian cancer, but not specifically with endometrioid endometrial carcinoma.
* **Option C:** Mutations in the KRAS gene are associated with various types of cancer, including colorectal and lung cancer, but not specifically with endometrioid endometrial carcinoma.

**Clinical Pearl / High-Yield Fact**
The presence of obesity and type 2 diabetes increases the risk of endometrial cancer, particularly endometrioid type, due to increased estrogen exposure and insulin resistance.

**Correct Answer:** C. PTEN (Phosphatase and Tensin Homolog)